• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Ipsen

18th birthday cupcake teenager young adult
Marketing

Ipsen initiative guides young adults aging out of pediatric care

Ipsen's new educational initiative is dedicated to supporting teens and young adults in transitioning from pediatric care to adult care.
Andrea Park Oct 24, 2025 11:18am
European Medicines Agency

ExCellThera's novel blood cancer cell therapy gains CHMP nod

Jun 20, 2025 11:55am
Loew

Ipsen touts early launch results for liver disease drug Iqirvo

Apr 17, 2025 8:47am
rare diseases

Arrowhead, Zevra fire up campaigns for Rare Disease Day 2025

Feb 28, 2025 10:18am
Image of a neon sign with the word no lit up next to an unlit yes

Apellis hit with yet another eye drug snub in Europe

Sep 20, 2024 10:06am
Product image of Exelixis 60mg Cabometyx

Exelixis plots FDA prostate cancer filing despite survival miss

Sep 16, 2024 5:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings